TMO

Thermo Fisher Scientific

Healthcare Diagnostics & Research NYSE

About the company

Thermo Fisher Scientific, a leading provider of scientific instruments, laboratory equipment, diagnostics consumables, and life science reagents, has continued to thrive and expand its operations since mid-2023. With a diverse range of offerings, the company serves various industries, including pharmaceutical, biotechnology, healthcare, and academia. The company's success can be attributed to its commitment to innovation, quality, and customer satisfaction. Thermo Fisher Scientific's analytical technologies segment has been instrumental in supporting advanced research and analysis across a wide range of applications. With a 16% share of total sales, this segment offers cutting-edge instrumentation and software solutions for chromatography, mass spectrometry, spectroscopy, and elemental analysis. Researchers and scientists rely on these technologies for precise analysis, making them crucial for industries like drug discovery, environmental testing, and forensics. In the specialty diagnostic products segment, accounting for 10% of sales, Thermo Fisher Scientific provides a range of diagnostic kits, assays, and reagents. These products play a vital role in diagnosing and monitoring diseases, including infectious diseases, cancer, genetic disorders, and autoimmune conditions. By offering accurate and reliable testing solutions, the company supports healthcare professionals in delivering prompt and efficient patient care. The life science solutions segment, representing 24% of sales, focuses on providing a comprehensive suite of solutions for life science research. Thermo Fisher Scientific offers a vast array of reagents, antibodies, nucleic acids, and cell culture media for genetic research, protein analysis, cell biology, and drug discovery. Additionally, the company offers advanced gene editing tools, such as CRISPR-Cas9, enabling researchers to explore new frontiers in genetic engineering and personalized medicine. With approximately 54% of sales, the lab products and services segment plays a significant role in Thermo Fisher Scientific's overall growth. This segment encompasses a wide range of laboratory equipment, consumables, and services, catering to the needs of research, academic, and industrial laboratories. The company supplies products like centrifuges, pipettes, incubators, and freezer systems, along with a comprehensive suite of lab consumables, including tubes, plates, and filtration products. Moreover, Thermo Fisher Scientific provides laboratory services through its Contract Research Organization (CRO) division, assisting customers in outsourcing various scientific services and accelerating their research and development processes. Thermo Fisher Scientific's continual investment in research and development has allowed them to introduce innovative products and expand their market presence. By collaborating with renowned researchers and academic institutions, the company remains at the forefront of scientific advancements. Moreover, strategic acquisitions and partnerships have strengthened Thermo Fisher Scientific's portfolio and enhanced its global reach. In conclusion, Thermo Fisher Scientific's success is attributable to its commitment to serving the scientific community with cutting-edge technologies, reliable diagnostic products, life science solutions, and lab products and services. With a customer-centric approach and a focus on innovation, the company continues to shape the future of scientific research and foster advancements in healthcare, diagnostics, and life sciences.

Website: https://www.thermofisher.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric TMO Sector median Vs. industry
P/E 27.17 20.10 ↑ Above average
EPS 18.18 USD -1.14 USD ↑ Above average
Dividend yield 0.36% 0.00% ↑ Above average
Profit margin 15.15% 0.00% ↑ Above average
ROE 13.52% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Thermo Fisher Scientific?
Thermo Fisher Scientific, a leading provider of scientific instruments, laboratory equipment, diagnostics consumables, and life science reagents, has continued to thrive and expand its operations since mid-2023. With a diverse range of offerings, the company serves various industries, including pharmaceutical, biotechnology, healthcare, and academia. The company's success can be attributed to its commitment to innovation, quality, and customer satisfaction. Thermo Fisher Scientific's analytical technologies segment has been instrumental in supporting advanced research and analysis across a wide range of applications. With a 16% share of total sales, this segment offers cutting-edge instrumentation and software solutions for chromatography, mass spectrometry, spectroscopy, and elemental analysis. Researchers and scientists rely on these technologies for precise analysis, making them crucial for industries like drug discovery, environmental testing, and forensics. In the specialty diagnostic products segment, accounting for 10% of sales, Thermo Fisher Scientific provides a range of diagnostic kits, assays, and reagents. These products play a vital role in diagnosing and monitoring diseases, including infectious diseases, cancer, genetic disorders, and autoimmune conditions. By offering accurate and reliable testing solutions, the company supports healthcare professionals in delivering prompt and efficient patient care. The life science solutions segment, representing 24% of sales, focuses on providing a comprehensive suite of solutions for life science research. Thermo Fisher Scientific offers a vast array of reagents, antibodies, nucleic acids, and cell culture media for genetic research, protein analysis, cell biology, and drug discovery. Additionally, the company offers advanced gene editing tools, such as CRISPR-Cas9, enabling researchers to explore new frontiers in genetic engineering and personalized medicine. With approximately 54% of sales, the lab products and services segment plays a significant role in Thermo Fisher Scientific's overall growth. This segment encompasses a wide range of laboratory equipment, consumables, and services, catering to the needs of research, academic, and industrial laboratories. The company supplies products like centrifuges, pipettes, incubators, and freezer systems, along with a comprehensive suite of lab consumables, including tubes, plates, and filtration products. Moreover, Thermo Fisher Scientific provides laboratory services through its Contract Research Organization (CRO) division, assisting customers in outsourcing various scientific services and accelerating their research and development processes. Thermo Fisher Scientific's continual investment in research and development has allowed them to introduce innovative products and expand their market presence. By collaborating with renowned researchers and academic institutions, the company remains at the forefront of scientific advancements. Moreover, strategic acquisitions and partnerships have strengthened Thermo Fisher Scientific's portfolio and enhanced its global reach. In conclusion, Thermo Fisher Scientific's success is attributable to its commitment to serving the scientific community with cutting-edge technologies, reliable diagnostic products, life science solutions, and lab products and services. With a customer-centric approach and a focus on innovation, the company continues to shape the future of scientific research and foster advancements in healthcare, diagnostics, and life sciences.
Are Thermo Fisher Scientific shares expensive?
The price-to-earnings (P/E) ratio of Thermo Fisher Scientific is 27.17 — the share price is 27.17 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is Thermo Fisher Scientific?
The market capitalization of Thermo Fisher Scientific — the combined value of all its shares — is 183.60 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Thermo Fisher Scientific pay dividends?
The dividend yield of Thermo Fisher Scientific is 0.36% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Thermo Fisher Scientific belong to?
Thermo Fisher Scientific operates in the Healthcare sector, industry: Diagnostics & Research.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120